165 Results for "

PAF

" in MedChemExpress (MCE) Product Catalog:
Products (165)

165 Results for "PAF" in MCE Product Catalog:

40
40 Publications Verification
Referencia número: HY-108635
No. CAS: 74389-68-7
Pureza:  99.85%
Synonyms: PAF (C16)
C16-PAF (PAF (C16)), a phospholipid mediator, is a platelet-activating factor and ligand for PAF G-protein-coupled receptor (PAFR). C16-PAF exhibits anti-apoptotic effect and inhibits caspase-dependent death by activating the PAFR. C16-PAF is a potent MAPK and MEK/ERK activator. C16-PAF induces increased vascular permeability .
3
3 Cited Publications
Referencia número: HY-108634
No. CAS: 105219-56-5
Pureza:  99.93%
Synonyms: WEB 2086
Áreas de investigación:  

Inflammation/Immunology

Apafant (WEB 2086), a chemical probe, is a potent platelet-activating factor (PAF) antagonist, inhibits PAF binding to human PAF receptors with a Ki of 9.9 nM. Apafant increases the gene expression of PAF-r, α-globin, β-globin, decreases the c-myb gene expression. Apafant shows a protective effect on alkyl-PAF-mediated lethalit .
2
2 Cited Publications
Referencia número: HY-13511A
No. CAS: 182349-12-8
Pureza:  98.77%
Synonyms: UR-12592 Fumarate
Áreas de investigación:  

Inflammation/Immunology

Rupatadine (UR-12592) Fumarate is a potent, orally active and long-lasting dual PAF/H1 antagonist, with Kis of 0.55 μM and 0.1 μM, respectively. Rupatadine Fumarate can be used for the research of allergic rhinitis and urticaria .
2
2 Cited Publications
Referencia número: HY-13511
No. CAS: 158876-82-5
Pureza:  99.70%
Synonyms: UR-12592
Áreas de investigación:  

Inflammation/Immunology

Rupatadine (UR-12592) is a potent, orally active and long-lasting dual PAF/H1 antagonist, with Kis of 0.55 μM and 0.1 μM, respectively. Rupatadine can be used for the research of allergic rhinitis and urticaria .
1
1 Cited Publications
Referencia número: HY-19354
No. CAS: 143901-35-3
Synonyms: Aglafolin; Rocaglamide U; (-)-Methyl rocaglate
Target:  

Potassium Channel

Áreas de investigación:  

Cardiovascular Disease

Aglafoline inhibits PAF-induced platelet aggregation, with an IC50 value of 50 μM.
Referencia número: HY-141570
No. CAS: 52691-62-0
Pureza:  ≥98.0%
Target:  

Phospholipase

Áreas de investigación:  

Others

Lyso-PAF C-16 is a precursor and metabolite of 1-O-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine (PAF C-16). Lyso-PAF C-16 is a substrate for either PAF C-16 formation by the remodeling pathway or selective acylation with arachidonic acid by a CoA-independent transacylase .
Referencia número: HY-130345
No. CAS: 74389-69-8
Pureza:  99.00%
Áreas de investigación:  

Cardiovascular Disease

C18-PAF, octadecane PAF, is the ligand of platelet-activating factor and PAF G protein-coupled receptor (PAFR). C18-PAF has renovasodilator properties and antihypertensive lipid properties. C18-PAF increases renal blood flow and causes dose-dependent systemic hypotension .
Referencia número: HY-109897
No. CAS: 100488-87-7
Pureza:  ≥98.0%
Áreas de investigación:  

Cardiovascular Disease

CV-6209 is a potent antagonist of platelet activating factor (PAF). CV-6209 inhibits the PAF-induced aggregation of rabbit and human platelets, with IC50s of 75 nM and 170 nM, respectively. CV-6209 can inhibit PAF-induced hypotension in rats .
Referencia número: HY-137257
No. CAS: 91575-58-5
Pureza:  ≥99.0%
Synonyms: C-PAF
Áreas de investigación:  

Inflammation/Immunology

Carbamyl-PAF is an analog and agonist of platelet-activating factor (PAF). Carbamyl-PAF is not significantly metabolized by Raji lymphoblasts at 37°C, making it a useful tool for inflammation research. .
Referencia número: HY-128694
No. CAS: 136468-36-5
Pureza:  99.97%
Synonyms: SR27417
Áreas de investigación:  

Cardiovascular Disease

Foropafant (SR27417) highly potent, competitive, selective and orally active antagonist of platelet-activating factor (PAF) receptor, with a Ki value of 57 pM for [ 3H]PAF binding, at least 5-fold lower than that of unlabeled PAF itself. Foropafant potently inhibits PAF-induced aggregation of rabbit and human platelets .
Referencia número: HY-141581
No. CAS: 74430-89-0
Pureza:  ≥98.0%
Lyso-PAF C-18 is an intermediate for the synthesis of C18-PAF (HY-130345). It has an easily substituted "Lyso-PAF" structure and is easy to purify and has high yield. C18-PAF is a ligand for platelet-activating factor and PAF G protein-coupled receptor (PAFR) and has renovasodilator properties and antihypertensive lipid properties .
Referencia número: HY-19121A
No. CAS: 121494-09-5
Áreas de investigación:  

Cancer

TCV-309 chloride is a potent and specific platelet activating factor (PAF) antagonist. TCV-309 chloride specifically inhibits PAF-induced aggregation of rabbit and human platelets, and [3H]PAF binding to rabbit platelet microsomes with IC50 values of 33 nM, 58 nM and 27 nM, respectively. TCV-309 chloride has beneficial effects in anaphylactic shock .
Referencia número: HY-N7343
No. CAS: 66280-26-0
Pregomisin is a natural compound isolated from the fruits of Schizandra chinensis Baill. Pregomisin showed PAF antagonistic activity and the IC50 values were 48 μM .
Referencia número: HY-160267
No. CAS: 950403-60-8
Target:  

HIV DNA/RNA Synthesis

Áreas de investigación:  

Infection Neurological Disease Cancer

iPAF1C is a inhibitor of the polymerase-associated factor 1 complex (PAF1C) with specific targeting to the PAF1 binding groove of CTR9 (a key subunit of PAF1C). iPAF1C disrupts PAF1C assembly by interfering with the PAF1-CTR9 interaction. iPAF1C selectively impairs BRD4-mediated recruitment of PAF1 to chromatin at hypoxia-responsive genes and inhibits RNA polymerase II (RNAPII) pause release. iPAF1C increases the population of HIV-1 NL4.3 Nef-IRES-GFP infected primary human CD4 +T cells in a dose-dependent manner. PAF1C can be used for the study of infection and diseases associated with abnormal hypoxic adaptation (e.g., cancers, neurological disorders) .
Referencia número: HY-W345359
No. CAS: 85966-90-1
Target:  

Endogenous Metabolite

Áreas de investigación:  

Inflammation/Immunology

PAF C-18:1 is a naturally occurring phospholipid produced by cells upon inflammatory responses. PAF C-18:1 is a chemoattractant, and induces human neutrophil chemotaxis .
Referencia número: HY-100164
No. CAS: 114606-56-3
Pureza:  99.77%
Synonyms: MKS 492
Áreas de investigación:  

Inflammation/Immunology

SDZ-MKS 492 (MKS 492) is a selective inhibitor of cyclic GMP-inhibited phosphodiesterase (type III PDE). SDZ-MKS 492 inhibits antigen- or platelet activating factor (PAF)-induced bronchoconstriction and allergic reactions in guinea pigs and rats .
Referencia número: HY-101263
No. CAS: 96801-55-7
Pureza:  ≥99.0%
Áreas de investigación:  

Others

2-Thio-PAF, a synthetic analog of PAF, is used in a colorimetric assay for PAF acetylhydrolases .
Referencia número: HY-147248
Synonyms: PAF-AS269
Target:  

EGFR

Áreas de investigación:  

Cancer

Opadotina is a small molecule of anvatabart opadotin. Opadotina shows antineoplastic activity .
Referencia número: HY-N4267
No. CAS: 13060-14-5
Yangambin is a PAF receptor antagonist and UGT1A1/UGT1A3 inhibitor, with an IC50 of 29.7 μM and a Ki of 17.1 μM against human UGT1A1, and an IC50 of 56.5 μM and a Ki of 66.8 μM against human UGT1A3. Yangambin blocks PAF-mediated responses, inhibits LTB4-mediated neutrophil infiltration, and suppresses inflammatory events and anaphylactic contraction. Yangambin acts as a central nervous system inhibitor to reduce spontaneous activity, and also exhibits analgesic, anticonvulsant, antileishmanial, vasodilatory and hypotensive effects. Yangambin blocks voltage-gated Ca 2+ channels, reduces the production of NO, TNF-α, IL-6 and PGE2 in cells, increases the production of IL-10, and exerts a protective effect against cardiovascular injury. Yangambin can be used in research related to allergies, cutaneous leishmaniasis, central nervous system diseases and cardiovascular diseases .
Referencia número: HY-141631
No. CAS: 155575-01-2
Synonyms: L-α-Phosphatidylcholine
Dihomo-γ-Linolenoyl PAF C-16is a PAFanalogue, it is in sn-2location contains dihomo-γ-linolenoate, instead of PAF C-16The acetate part in .